Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
151.32%
2026 (actual)
ROA
-142.88%
2026 (actual)
Gross Margin
-
Net Margin
-
Total Assets
A$8,528.11K
2026 (actual)
Net Income
-A$14,961.43K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
-101.3 pt
Company
ROA
-705.3 pt
Company
Total Assets
-31.6%
Company
Sector average (own scale)
Net Income
-777.9%
Company
Sector average
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for RECCE PHARMACEUTICALS LTD? It covers the balance sheet, income statement, cash flow and Equlion model projections.